These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12742997)

  • 21. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).
    Teupser D; Persky AD; Breslow JL
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1907-13. PubMed ID: 12907460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice.
    Li D; Liu Y; Chen J; Velchala N; Amani F; Nemarkommula A; Chen K; Rayaz H; Zhang D; Liu H; Sinha AK; Romeo F; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):701-7. PubMed ID: 16631603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
    Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques.
    He L; Game BA; Nareika A; Garvey WT; Huang Y
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):212-22. PubMed ID: 17110803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
    Mujynya-Ludunge K; Viswambharan H; Driscoll R; Ming XF; von Segesser LK; Kappenberger L; Yang Z; Vassalli G
    Basic Res Cardiol; 2005 Mar; 100(2):102-11. PubMed ID: 15578196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J; Miller BA; Lin RC
    Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
    Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Hough G; Wagner A; Nakamura K; Garber DW; Datta G; Segrest JP; Hama S; Fogelman AM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1100-4. PubMed ID: 14582455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.
    Tangirala RK; Tsukamoto K; Chun SH; Usher D; Puré E; Rader DJ
    Circulation; 1999 Oct; 100(17):1816-22. PubMed ID: 10534470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties.
    Graversen JH; Laurberg JM; Andersen MH; Falk E; Nieland J; Christensen J; Etzerodt M; Thøgersen HC; Moestrup SK
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):170-7. PubMed ID: 18287885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
    Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
    Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.